
BiotechTV - News Pareto Securities' Healthcare Conference: Cinclus Pharma is trying to user in the next generation of acid reflux medicines with, linaprazan glurate, a potassium-competitive acid blocker (P-CAB)
Sep 16, 2025
Chapters
Transcript
Episode notes
